Every little hero deserves a fighting chance. Together, we’re making that possible—one heartbeat at a time.
As a global healthcare company, Abbott is committed to the research and development of life-changing technologies for newborns and children with heart problems. We partner with organizations and physicians dedicated to giving these children the best possible treatment.
With Little Heroes, we support children with congenital heart defects in developing countries, where there is limited access to healthcare. Abbott provides life-changing technologies and additional support to help give these children the chance to grow up and reach their full potential.
If you have any questions, feedback, or comments about this website,
please don't hesitate to get in touch with us.
MAT-2509788 v1.0 | Item approved for Global use.
References
1. Van der Linde S., Birth Prevalence of Congenital Heart Disease Worldwide. A Systematic Review and Meta-Analysis, J Am Coll Cardiol 2011;58:2241–7 / medlineplus.gov/congenitalheartdefects.html / www.cdc.gov/ncbddd/heartdefects/facts.html
2. Hoffmann J., The global burden of congenital heart disease Cardiovasc J Afr 2013; 24: 141–145
3. Oster M, Lee K, Honein M, Colarusso T, Shin M, Correa A. Temporal trends in survival for infants with critical congenital heart defects. Pediatrics. 2013;131(5):e1502-8
4. Greenwell, A.A.; Deng, M.X.; Ross, S.; Weixler, V.; Vervoort, D. Socioeconomic Status and Access to Care for Pediatric and Adult Congenital Heart Disease in Universal Health Coverage Models. J. Cardiovasc. Dev. Dis. 2024, 11, 250. https://doi.org/10.3390/jcdd11080250